Consumer Health

 

The growing and aging world population represents an increasing challenge to public health care systems. For this reason, the issue of self-care is gaining importance for millions of people, as well as for governments, health care systems and health care payers.

Our Consumer Health division is responding to this change with its mainly nonprescription (OTC) brand products to treat and prevent diseases and to improve well-being, providing consumers with the corresponding self-care solutions. Our strategy is aimed at further building on our strong position in the market for over-the-counter medicines, nutritional supplements and other self-care products in selected categories.

Increasing competition for consumer attention combined with ongoing industry and distribution channel consolidation require a stronger focus on brand building, key markets and consumer-centric innovation. In order to drive the organic growth of our core brands, such as Claritin™, Aspirin™, Aleve™, Bepanthen™, Canesten™, Alka-Seltzer™, Dr. Scholl’s™, One a Day™, Coppertone™, Elevit™ and Berocca™, we are investing in product innovation and geographical expansion. We additionally intend to further strengthen our positions in key markets such as the United States, Brazil, Russia and China through product developments, marketing innovations and new digital offerings.

Fit in Old Age: Best Ager in Florida

We also plan to continue selectively pursuing external growth opportunities that arise from the progressive consolidation of the OTC industry in order to expand our presence in strategic focus categories and markets by way of acquisitions.

Group target 2017: Transition of

25

consumer-validated concepts into early development.

A Tradition in Self-Medication

Over-the-counter (OTC) brands, nutritional supplements and other self-care products play a key role in help people to stay healthy.
The over-65s are the fastest-growing section of the population.
There is a crucial need to ensure healthy lives and promote well-being for all ages.
Pollen dispersal can be simulated in the allergy room at the Consumer Center in Memphis, Tennessee. Venkat Venkatakrishnan (right) monitors the pollen concentration in the room, which is designed for up to 12 people.

901 million

people worldwide were aged over 60 in 2015. By 2050, this figure will have more than doubled to about two billion – almost every fifth person on the planet.

Consumer Health can look back on a long tradition in the self-medication market. It began in 1899 with the introduction of Aspirin™, Bayer’s world-renowned iconic brand.


Today, the division operates in more than 100 countries, maintaining 18 production sites and four product research and development centers. Our development strategies are focused on expanding and enhancing our brand portfolio. We aim to achieve this by developing new products along with new delivery forms, formulations, product messages, novel packaging forms and other innovations. We also actively pursue the reclassification of current prescription medicines as OTC products.

Strategy: Building on a Strong Position

At Consumer Health, we are working together to lead a global transformation – from treating illness to promoting wellness. We are working together to help every consumer we serve lead a better, healthier life through science-driven innovations that improve wellness, treat everyday ailments and prevent disease.

The growing and aging world population represents an increasing challenge to public health care systems. For this reason, the issue of self-care is gaining importance for millions of people, as well as for governments, health care systems and health care payers.

Our Consumer Health segment is responding to this change with its mainly nonprescription (OTC) brand products to treat and prevent diseases and to improve well-being, providing consumers with the corresponding self-care solutions. Our strategy is aimed at further building on our strong position in the market for over-the-counter medicines, nutritional supplements and other self-care products in selected categories.

Increasing competition for consumer attention combined with ongoing industry and distribution channel consolidation require a stronger focus on brand building, key markets and consumer-centric innovation. In order to drive the organic growth of our core brands, such as Claritin™, Aspirin™, Aleve™, Bepanthen™, Canesten™, Alka-Seltzer™, Dr. Scholl’s™, One a Day™, Coppertone™, Elevit™ and Berocca™, we are investing in product innovation and geographical expansion. We additionally intend to further strengthen our positions in key markets such as the United States, Brazil, Russia and China through product developments, marketing innovations and new digital offerings.

We also plan to continue selectively pursuing external growth opportunities that arise from the progressive consolidation of the OTC industry in order to expand our presence in strategic focus categories and markets by way of acquisitions.

Last updated: February 23, 2017 Copyright © Bayer AG
https://www.bayer.com